[ Price : $8.95]
FDA signals that increased regulatory oversight might be on the horizon for unapproved animal-derived thyroid medications, which a...[ Price : $8.95]
Krieger Scientific founder Joseph Morwald says a surge in FDA drug Warning Letters is driven by an industry systemic problem that ...[ Price : $8.95]
AdvaMed voices strong public support for the MDUFA 6 commitment reached with FDA.[ Price : $8.95]
FDA grants acelerated approval to Replimune for its Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic vi...[ Price : $8.95]
The International Medical Device Regulators Forum releases a final document outlining global principles for Predetermined Change C...[ Price : $8.95]
FDA accepts for review a Merck supplemental BLA for Enflonsia (clesrovimab-cfor) to expand its indication to include preventing re...[ Price : $8.95]
Two senior U.S. senators seek answers from FDA about its plans to address ongoing shortages of several critical chemotherapy drugs...[ Price : $8.95]
FDA outlines its intention to overhaul the early-stage clinical development process through a planned Expedited IND Pilot, arguing...